Castle Creek Biosciences

Castle Creek Biosciences is a clinical-stage cell and gene therapy company focused on developing and commercializing personalized, disease-modifying therapies for patients with rare diseases lacking effective treatments, leveraging its proprietary autologous fibroblast technology platform. The company aims to address the underlying causes of disease by creating localized treatments tailored to each patient’s unique biology, positioning itself as a specialized innovator in the rare disease therapeutics market.

Company Facts

• Headquarters: Exton, United States
• Employees: 53
• Type: Private Company
• Website: https://www.castlecreekbio.com
• Industries: Biotechnology, Cell Therapy, Gene Therapy, Rare Diseases, Personalized Medicine